Xylo Technologies (MDGS) Stock Price, News & Analysis

Company Overview

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Key Stats

• Today's Range: N/A
• 50-Day Range: $2.18 to $2.95
• 52-Week Range: N/A
• Volume: 28,800 shs
• Average Volume: 9,658 shs
• Market Capitalization: $3.92 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MDGS Stock Analysis - Frequently Asked Questions

When did Xylo Technologies' stock split?

Xylo Technologies's stock reverse split on Monday, November 14th 2022. The 1-15 reverse split was announced on Monday, November 14th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, November 14th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Xylo Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Xylo Technologies investors own include Meta Platforms (META), NVIDIA (NVDA), GE Aerospace (GE), Broadcom (AVGO), CymaBay Therapeutics (cbay), CrowdStrike (CRWD) and

Company Calendar

• Today: 5/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: NASDAQ:MDGS
• CIK: 1618500
• Web: www.medigus.com
• Phone: 972-73-370-4691
• Fax: 972-72-260-2249
• Employees: 77
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $91.86 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $51.82 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,660,000
• Free Float: 1,622,000
• Market Cap: $3.92 million
• Optionable: Optionable
• Beta: 0.31